| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 06/21/2012 | WO2012061113A3 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis |
| 06/21/2012 | US20120157395 Anti-inflammatory agent for oral application, and anti-inflammatory peptide for oral application |
| 06/21/2012 | US20120157394 Selective caspase inhibitors and uses thereof |
| 06/21/2012 | US20120157387 Orally bioavailable d-gamma-glutamyl-d-tryptophan |
| 06/21/2012 | US20120156276 Connective tissue stimulating peptides |
| 06/21/2012 | US20120156215 Phage-GnRH Constructs, Their Mimics, Antigenic Compositions, and Sequences for Immunocontraception of Animals and Other Applications |
| 06/21/2012 | CA2817365A1 Process and intermediates for preparing macrolactams |
| 06/20/2012 | EP2464637A1 Sultone compound derivatives substituted by nucleophiles, in particular radionuclides, and use thereof for marking macromolecules |
| 06/20/2012 | EP2099815B1 Novel amides acting on the adenosine receptors |
| 06/20/2012 | EP1912996B1 Macrocyclic inhibitors of hepatitis c virus |
| 06/20/2012 | CN102504014A Peptidomimetic protease inhibitors |
| 06/20/2012 | CN102504013A Target chemical drug PADM against cancer metastasis and preparation method and use thereof |
| 06/20/2012 | CN102504012A Preparation method of fullerene reduced glutathione derivative |
| 06/20/2012 | CN101838628B Method for producing L-amino acids using bacteria belonging to the genus escherichia |
| 06/20/2012 | CN101233147B Macrocyclic inhibitors of hepatitis c virus |
| 06/14/2012 | US20120149651 Caveolin peptides and their use as therapeutics |
| 06/14/2012 | US20120149062 High Purity Lipopeptides |
| 06/14/2012 | CA2819810A1 Granzyme b inhibitor compositions, methods and uses for promoting wound healing |
| 06/13/2012 | EP2463285A1 Co-crystals and pharmaceutical compositions comprising the same |
| 06/13/2012 | EP2463284A1 Co-crystals and pharmaceutical compositions comprising the same |
| 06/13/2012 | EP2461830A1 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| 06/13/2012 | CN102498201A Method and apparatus for the analysis and identification of molecules |
| 06/13/2012 | CN102498124A Cyclic amino acid molecules and methods of preparing the same |
| 06/13/2012 | CN102492021A Preparation process for bortezomib |
| 06/13/2012 | CN102492020A Pidotimod compound and new preparation method thereof |
| 06/13/2012 | CN102492019A Silkworm protein source dipeptide TE and its purpose |
| 06/13/2012 | CN102492018A Tyrosinase polypeptide inhibitor |
| 06/12/2012 | US8198405 Stabilized alpha helical peptides and uses thereof |
| 06/12/2012 | US8198400 Liposomal vaccines containing immunogenic lipopeptides from tuberculosis, malaria, and hepatitis B peptides |
| 06/12/2012 | US8198242 Variants of C-type natriuretic peptide |
| 06/12/2012 | CA2560897C Macrocyclic compounds as inhibitors of viral replication |
| 06/07/2012 | WO2012074120A1 Lissencephaly therapeutic agent |
| 06/07/2012 | US20120142616 Antineoplastic Hydrogels, and Enzyme-Instructed Preparations Thereof |
| 06/07/2012 | US20120142615 Methods related to the treatment of neurodegenerative and inflammatory conditions |
| 06/07/2012 | US20120141496 Iap bir domain binding compounds |
| 06/07/2012 | US20120141414 Bimacrocylic HCV NS3 Protease Inhibitors |
| 06/06/2012 | EP2460814A1 Peptidic compound and use of same |
| 06/06/2012 | EP2459582A1 Hepatitis c virus ns3 protease inhibitors |
| 06/06/2012 | EP2459525A1 Enantio- and stereo-specific syntheses of -amino- - hydroxy amides |
| 06/06/2012 | CN1367789B Synthesis of template-fixed beta-hairpin loop mimetics |
| 06/06/2012 | CN102485745A Thrombolytic oligopeptides, preparation method and application thereof |
| 06/06/2012 | CN102485744A Thrombolytic oligopeptide compound, its preparation method and application |
| 06/06/2012 | CN102485743A Antineoplastic compound |
| 06/06/2012 | CN101830937B Visualized double-reaction tube fluorine-18 multifunctional automated synthesis module |
| 06/05/2012 | US8193346 Process for making macrocyclic oximyl hepatitis C protease inhibitors |
| 06/05/2012 | US8193312 Bone morphogenic protein binding peptide |
| 06/05/2012 | CA2324226C Inhibitors of caspases |
| 05/31/2012 | WO2012070554A1 Peptide |
| 05/31/2012 | WO2012033993A3 Methods for assaying enzyme activities |
| 05/31/2012 | WO2011156045A3 Tablet formulation of ezatiostat |
| 05/31/2012 | US20120136416 Caged Neuropeptides: modulation and measurement of synapse and signaling activity; and methods for drug evaluation, pharmaceuticals preparation and treatment |
| 05/31/2012 | US20120135921 Tripetide boronic acid or boronic ester, preparative method and use thereof |
| 05/31/2012 | US20120135917 Anti-Gram Negative Bacteria Agent |
| 05/31/2012 | US20120134977 Prodrugs containing albumin binding probe |
| 05/30/2012 | EP2457925A1 Process for preparing a macrocyclic modulator of the ghrelin receptor and intermediates |
| 05/30/2012 | EP2457896A1 Tripeptides as caspase modulators |
| 05/30/2012 | EP2457895A1 Tetrapeptide analogs |
| 05/30/2012 | EP2457593A1 Cyclic RGD peptides of amino acids based on thiazoles or oxazoles as selective antagonists of the alpha-v beta-3 integrin |
| 05/30/2012 | CN1985000B T-cell death-inducing epitopes |
| 05/30/2012 | CN102482322A 肽组合物 Peptide composition |
| 05/30/2012 | CN102477070A 具有溶血栓活性的寡肽及其制备方法和应用 Oligopeptide and its preparation method and application having thrombolytic activity |
| 05/30/2012 | CN102477069A Pro-Ala-Lys-Asp[OCH<sub>2</sub>(CH<sub>2</sub>)nCH<sub>3</sub>]-OCH<sub>2</sub>(CH<sub>2</sub>)nCH<sub>3</sub>、及其合成和作为溶血栓剂的应用 Pro-Ala-Lys-Asp [OCH <sub> 2 </ sub> (CH <sub> 2 </ sub>) nCH <sub> 3 </ sub>] - OCH <sub> 2 </ sub> (CH Applications <sub> 2 </ sub>) nCH <sub> 3 </ sub>, its synthesis and as a thrombolytic agent |
| 05/30/2012 | CN102477068A 用于制备溶血栓药物的氨基酸衍生物及其制备方法和应用 Amino acid derivative and its preparation method and application for the preparation of thrombolytic drugs |
| 05/30/2012 | CN102477067A 3-氨基-2-羟基-4-苯基-缬氨酰-异亮氨酸及其制备方法和应用 3-amino-2-hydroxy-4-phenyl - valyl - isoleucine and its preparation method and application |
| 05/30/2012 | CN102477066A N-(s-1,2,3,4-四氢-6,7-二羟基异喹啉-3-甲酰)氨基酸及其合成方法和应用 N- (s-1,2,3,4- tetrahydro-6,7-dihydroxy-isoquinoline-3-carboxylic acid) amino acids and the synthesis method and application |
| 05/30/2012 | CN101928328B RGD peptide-epimedium flavone combination, preparation method and application thereof |
| 05/30/2012 | CN101565449B N-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester |
| 05/29/2012 | US8188247 Conjugates and compositions for cellular delivery |
| 05/29/2012 | US8188230 Method for recombinant microorganism expression and isolation of collagen-like polypeptides |
| 05/29/2012 | US8188228 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 05/29/2012 | US8188222 High molecular weight derivative of nucleic acid antimetabolite |
| 05/29/2012 | US8188219 Cyclic peptide for use in diagnosis, prevention and treatment of bone disorders |
| 05/29/2012 | US8188216 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
| 05/29/2012 | US8188215 Metal-binding compounds and uses therefor |
| 05/29/2012 | US8188214 Brachyury polypeptides and methods for use |
| 05/29/2012 | US8188049 Peptides having activities of epidermal growth factor and its uses |
| 05/29/2012 | US8188033 Anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity |
| 05/29/2012 | CA2516016C Hepatitis c inhibiting compounds |
| 05/29/2012 | CA2463985C Crystals of glutathione oxidized and process for production thereof |
| 05/29/2012 | CA2389429C Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 05/29/2012 | CA2361292C A novel chimeric protein for prevention and treatment of hiv infection |
| 05/29/2012 | CA2341340C Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor |
| 05/29/2012 | CA2338005C Peptide antagonists of zonulin and methods for use of the same |
| 05/29/2012 | CA2220777C Novel heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists |
| 05/24/2012 | WO2012067947A1 Lipoyl compounds and their use for treating ischemic injury |
| 05/24/2012 | WO2012066549A1 Dipeptide analogs for treating conditions associated with amyloid fibril formation |
| 05/24/2012 | WO2012006497A3 Mu opioid receptor agonist analogs of the endomorphins |
| 05/24/2012 | US20120129779 Tubulysine derivatives |
| 05/24/2012 | US20120129765 Novel specific hcv ns3 protease inhibitors |
| 05/24/2012 | US20120129264 Method for Transforming a Bacterium Belonging to the Streptococcus Genus by Natural Competence |
| 05/24/2012 | US20120129203 Novel Peptidase Substrates |
| 05/24/2012 | CA2817830A1 Dipeptide analogs for treating conditions associated with amyloid fibril formation |
| 05/24/2012 | CA2817362A1 Lipoyl compounds and their use for treating ischemic injury |
| 05/23/2012 | EP2455105A2 Bombesin analogues |
| 05/23/2012 | EP1446418B1 Integrin targeting compounds |
| 05/23/2012 | CN102471369A 肽类化合物及其用途 Peptide compounds and their uses |
| 05/23/2012 | CN102464701A New type compound, its preparation method and application |
| 05/23/2012 | CN102464654A 新型抗病毒化合物 Novel antiviral compounds |
| 05/23/2012 | CN101899090B Saturated fatty chain alcohol His-Gly-AA tripeptide ester, synthetic method and application thereof |
| 05/23/2012 | CN101899087B Saturated fatty chain amine Glu-Asp-Gly tripeptide amides as well as synthesis method and application thereof |